Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Brown

Showing results (51-60 of 289) with videos related to

Pageof 29
Sort By:
Current Eye Research|November 18, 2022
HAWK Extension Study: Safety and Efficacy of Intravitreal Brolucizumab in Neovascular Age-related Macular DegenerationDavid M Brown, Marta Nowik, Emmanuel Bouillaud, et al.
Nanotechnology|May 1, 2010
Interaction between nanoparticles and cytokine proteins: impact on protein and particle functionalityDavid M Brown, Claire Dickson, Paul Duncan, et al.
Retina (Philadelphia, Pa.)|November 26, 2013
Outcomes of macular hole surgeries for macular telangiectasia type 2Peter A Karth, Sharath C Raja, David M Brown, et al.
Chemosphere|December 24, 2017
Assessing the suitability of a manometric test system for determining the biodegradability of volatile hydrocarbonsDavid M Brown, Christopher B Hughes, Michael Spence, et al.
Nanotechnology|November 21, 2015
Exploring the cellular and tissue uptake of nanomaterials in a range of biological samples using multimodal nonlinear optical microscopyHelinor J Johnston, Rabah Mouras, David M Brown, et al.
American Journal of Ophthalmology|May 28, 2017
Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal DiseasesWilliam C Ou, David M Brown, John F Payne, et al.
Cell Biology and Toxicology|September 12, 2007
Reduced alveolar macrophage migration induced by acute ambient particle (PM10) exposurePeter G Barlow, David M Brown, Ken Donaldson, et al.
The British Journal of Ophthalmology|February 13, 2014
Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial)Charles C Wykoff, David M Brown, Maria E Maldonado, et al.
Journal of Business Research|December 21, 2022
Sustainability in the beer and pub industry during the COVID-19 period: An emerging new normalPallavi Singh, David M Brown, Jessica Chelekis, et al.
Retina (Philadelphia, Pa.)|September 24, 2015
Reply: To PMID 24914476David M Brown, Charles C Wykoff, Daniel E Croft, et al.
Pageof 29

Showing results (51-60 of 289) with videos related to

Sort By:
Pageof 29
Current Eye Research|November 18, 2022
HAWK Extension Study: Safety and Efficacy of Intravitreal Brolucizumab in Neovascular Age-related Macular DegenerationDavid M Brown, Marta Nowik, Emmanuel Bouillaud, et al.
Nanotechnology|May 1, 2010
Interaction between nanoparticles and cytokine proteins: impact on protein and particle functionalityDavid M Brown, Claire Dickson, Paul Duncan, et al.
Retina (Philadelphia, Pa.)|November 26, 2013
Outcomes of macular hole surgeries for macular telangiectasia type 2Peter A Karth, Sharath C Raja, David M Brown, et al.
Chemosphere|December 24, 2017
Assessing the suitability of a manometric test system for determining the biodegradability of volatile hydrocarbonsDavid M Brown, Christopher B Hughes, Michael Spence, et al.
Nanotechnology|November 21, 2015
Exploring the cellular and tissue uptake of nanomaterials in a range of biological samples using multimodal nonlinear optical microscopyHelinor J Johnston, Rabah Mouras, David M Brown, et al.
American Journal of Ophthalmology|May 28, 2017
Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal DiseasesWilliam C Ou, David M Brown, John F Payne, et al.
Cell Biology and Toxicology|September 12, 2007
Reduced alveolar macrophage migration induced by acute ambient particle (PM10) exposurePeter G Barlow, David M Brown, Ken Donaldson, et al.
The British Journal of Ophthalmology|February 13, 2014
Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial)Charles C Wykoff, David M Brown, Maria E Maldonado, et al.
Journal of Business Research|December 21, 2022
Sustainability in the beer and pub industry during the COVID-19 period: An emerging new normalPallavi Singh, David M Brown, Jessica Chelekis, et al.
Retina (Philadelphia, Pa.)|September 24, 2015
Reply: To PMID 24914476David M Brown, Charles C Wykoff, Daniel E Croft, et al.
Pageof 29